Gyre Therapeutics, Inc. GYRE Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Gyre Therapeutics, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s change in lease liabilities?
- Gyre Therapeutics, Inc. (GYRE) reported change in lease liabilities of -$236K in Q4 2025.
- How has Gyre Therapeutics, Inc.'s change in lease liabilities changed year-over-year?
- Gyre Therapeutics, Inc.'s change in lease liabilities increased by 89.5% year-over-year, from -$2.24M to -$236K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s change in lease liabilities?
- Over 2 years (2022 to 2024), Gyre Therapeutics, Inc.'s change in lease liabilities has grown at a 37.9% compound annual growth rate (CAGR), from -$429K to -$816K.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.